Both in Surgical Instruments
Medline vs DexCom
Over the past year MDLN returned −16.9% and DXCM returned +26.2%; their daily moves had a correlation of 0.24.
MDLN −16.9% DXCM +26.2%Growth of $1, one year, split-adjusted
| Metric | MDLN | DXCM |
|---|---|---|
| Price | $34.09 | $82.97 |
| Market cap | $29.91B | $30.94B |
| Today | +1.37% | −2.11% |
| 1 month | −4.8% | −4.5% |
| 6 months | −24.8% | +39.5% |
| Year to date | −18.8% | +25.0% |
| 1 year | — | +42.5% |
| Revenue growth (YoY) | — | +11.2% |
| Gross margin | 28.8% | 64.3% |
| Net margin | 0.8% | 20.5% |
| P/E (TTM) | — | 31.2× |
| Price / sales | — | 6.1× |
| Net cash | -$9.90B | $574.2M |
| Dividend yield | — | — |
| Volatility (60d) | 35.8% | 29.4% |
| Short % of float | 13.2% | 4.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).